Stream 3a applications must include collaboration between at least one
industry and one research (academic or clinical) partner aiming to
determine the commercial viability of a proposed device or technology, with
the development of a robust route to market and a strong, appropriate
consortia serving as key deliverables. Primarily expected to be the first
stage of a full collaborative applied research project, total project costs can
be no more than £100K in total, of which 75% funding is available. |
